These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17307535)

  • 1. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms.
    Kabra NS; Schmidt B; Roberts RS; Doyle LW; Papile L; Fanaroff A;
    J Pediatr; 2007 Mar; 150(3):229-34, 234.e1. PubMed ID: 17307535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus.
    Alexander F; Chiu L; Kroh M; Hammel J; Moore J
    J Pediatr Surg; 2009 Jan; 44(1):112-7; disscusion 117. PubMed ID: 19159727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.
    Yang CZ; Lee J
    World J Pediatr; 2008 May; 4(2):91-6. PubMed ID: 18661761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants.
    Mosalli R; Alfaleh K
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD006181. PubMed ID: 18254095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003951. PubMed ID: 18254035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.
    Weisz DE; Mirea L; Rosenberg E; Jang M; Ly L; Church PT; Kelly E; Kim SJ; Jain A; McNamara PJ; Shah PS
    JAMA Pediatr; 2017 May; 171(5):443-449. PubMed ID: 28264088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).
    Schmidt B; Roberts RS; Fanaroff A; Davis P; Kirpalani HM; Nwaesei C; Vincer M;
    J Pediatr; 2006 Jun; 148(6):730-734. PubMed ID: 16769377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms.
    Alfaleh K; Smyth JA; Roberts RS; Solimano A; Asztalos EV; Schmidt B;
    Pediatrics; 2008 Feb; 121(2):e233-8. PubMed ID: 18245398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.
    Mirea L; Sankaran K; Seshia M; Ohlsson A; Allen AC; Aziz K; Lee SK; Shah PS;
    J Pediatr; 2012 Oct; 161(4):689-94.e1. PubMed ID: 22703954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
    Liebowitz M; Clyman RI
    J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus.
    Sallmon H; Weber SC; Hüning B; Stein A; Horn PA; Metze BC; Dame C; Bührer C; Felderhoff-Müser U; Hansmann G; Koehne P
    Pediatrics; 2012 Sep; 130(3):e623-30. PubMed ID: 22869835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.
    Schmidt B; Davis P; Moddemann D; Ohlsson A; Roberts RS; Saigal S; Solimano A; Vincer M; Wright LL;
    N Engl J Med; 2001 Jun; 344(26):1966-72. PubMed ID: 11430325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.
    Adrouche-Amrani L; Green RS; Gluck KM; Lin J
    BMC Pediatr; 2012 Jan; 12():10. PubMed ID: 22284694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?
    Kaempf JW; Wu YX; Kaempf AJ; Kaempf AM; Wang L; Grunkemeier G
    J Perinatol; 2012 May; 32(5):344-8. PubMed ID: 21818064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
    Schmidt B; Asztalos EV; Roberts RS; Robertson CM; Sauve RS; Whitfield MF;
    JAMA; 2003 Mar; 289(9):1124-9. PubMed ID: 12622582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants.
    Noori S; Patel D; Friedlich P; Siassi B; Seri I; Ramanathan R
    J Perinatol; 2009 Aug; 29(8):553-7. PubMed ID: 19461594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of failed closure of patent ductus arteriosus with indomethacin.
    Boo NY; Mohd-Amin I; Bilkis AA; Yong-Junina F
    Singapore Med J; 2006 Sep; 47(9):763-8. PubMed ID: 16924357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
    Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
    Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.